What is LGND stock price today?

Visit our real-time dashboard for the current LGND stock price and live market data.

Is LGND stock going up or down today?

LGND stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy LGND stock now?

The decision to buy LGND depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is LGND a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for LGND based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is LGND stock overvalued or undervalued?

Use our DCF valuation calculator to determine if LGND is overvalued or undervalued based on fundamental analysis and future cash flow projections.

What is LGND's P/E ratio?

P/E ratio data for LGND will be available after the company reports earnings. Visit our dashboard for the latest financial metrics.

What is LGND's market cap?

LGND (Ligand Pharmaceuticals Incorporated) has a market capitalization of $2.21 billion, making it a small-cap stock.

What is LGND's price to book ratio?

Price-to-book ratio for LGND is available on our dashboard along with other valuation metrics.

Does LGND pay dividends?

LGND does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.

What is LGND's dividend yield?

LGND does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.

Is LGND stock a good long-term investment?

LGND's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is LGND's revenue growth rate?

Revenue growth data for LGND is available on our dashboard with detailed financial statement analysis.

Profitability metrics for LGND are available on our dashboard with complete income statement analysis.

What are the risks of investing in LGND?

Key risks for LGND include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does LGND compare to its competitors?

Compare LGND to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize LGND's performance and positioning.

What is LGND's stock price target for 2026?

Visit our prediction page for AI-powered price targets for LGND with bull, base, and bear case scenarios.

What do analysts say about LGND?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for LGND. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is LGND's next earnings report?

LGND reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

LGND - Ligand Pharmaceuticals Incorporated

NYSE * Healthcare * Biotechnology

$0.00

+$0.00 (+0.00%)

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Incorporated (LGND) common stock

Price Chart

Loading chart...

LGND Key Statistics

Market Cap

$2.21B

How LGND Compares to Peers

LGND is the smallest among peers, which may offer higher growth potential

P/E Rank

N/A

of 4

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 5

Company	Market Cap	P/E	Growth	Margin	Compare
LGND(This stock)	$2.21B	N/A	0%	0.0%	-
AMGNAmgen Inc	$188.67B	24.3	0%	0.0%	vs AMGN
GILDGilead Sciences	$160.15B	17.5	0%	0.0%	vs GILD
VRTXVertex Pharmaceuticals	$106.87B	29.7	0%	0.0%	vs VRTX
REGNRegeneron Pharmaceuticals	$59.10B	13.9	0%	0.0%	vs REGN

Data Updated: June 15, 2026 at 6:51 AM EDT

Ready to invest in LGND?

Commission-free trading available. Affiliate links.

Upcoming Events for LGND

Dashboard

Enter a ticker to analyze